CRYL1 Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6802b
Background:
The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. This protein catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate.
Other Names:
Lambda-crystallin homolog, L-gulonate 3-dehydrogenase, Gul3DH, CRYL1, CRY
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6802b was selected from the C-term region of human CRYL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CRYL1
Gene ID: 51084
Primary Accession: Q9Y2S2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. This protein catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate.
Other Names:
Lambda-crystallin homolog, L-gulonate 3-dehydrogenase, Gul3DH, CRYL1, CRY
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6802b was selected from the C-term region of human CRYL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CRYL1
Gene ID: 51084
Primary Accession: Q9Y2S2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review